SRAX Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

SRAX şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Recent updates

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: SRAX şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: SRAX şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

SRAX Piyasaya Karşı Temettü Getirisi

SRAX temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (SRAX)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.4%
Sektör Ortalaması (Software)	0.8%
Analist tahmini (SRAX) (3 yıla kadar)	n/a

Önemli Temettü: SRAX şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, SRAX şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: SRAX şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: SRAX herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

SRAX Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

SRAX, Inc. (NasdaqCM:SRAX) announces an Equity Buyback for $10 million worth of its shares.

Recent updates

DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc. (OTCPK:SRAX).

SRAX, Inc. announced that it has received $0.075 million in funding

SRAX, Inc. announced that it has received $0.075 million in funding

SRAX, Inc. Announces Resignation of Board Members

Alan Urban Resigns as the Chief Financial Officer of SRAX, Inc

New major risk - Market cap size

First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.57 loss in 1Q 2021)

Forecast breakeven date pushed back to 2023

SRAX, Inc., Annual General Meeting, Dec 31, 2022

Price target increased to US$10.50

SRAX, Inc. Launches the Sequire Investor Community Platform

SRAX Announces Receipt of Nasdaq Listing Determination

SRAX gets Nasdaq delisting notice, plans to appeal decision

Full year 2021 earnings released: US$0.41 loss per share (vs US$0.69 loss in FY 2020)

SRAX, Inc. Announces the Arcimoto Sweepstakes

SRAX Announces Receipt of Anticipated Nasdaq Notice of Additional Delinquency

Srax receives Nasdaq notice of additional delinquency

Is There An Opportunity With SRAX, Inc.'s (NASDAQ:SRAX) 50% Undervaluation?

Price target increased to US$10.50

SRAX announces $9.5M revolving credit facility

SRAX, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022

SRAX, Inc. announced delayed 10-Q filing

SRAX, Inc. Receives Non-Compliance Notice from Nasdaq

SRAX, Inc. announced delayed annual 10-K filing

SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022

Is SRAX (NASDAQ:SRAX) A Risky Investment?

SRAX Offers Value Here

Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.45 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.24 loss per share (vs US$0.38 loss in 2Q 2020)

Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?

SRAX Is Booming, Except The Share Price

Consensus forecasts updated

SRAX, Inc. (NasdaqCM:SRAX) announces an Equity Buyback for $10 million worth of its shares.

Price target increased to US$9.75

SRAX Releases the 1x1 Meeting Feature on the Sequire Virtual Events Platform

SRAX Has Plenty Of Room To Run

SRAX, Inc. announced delayed 10-Q filing

SRAX, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal 2021

Full year 2020 earnings released: US$0.92 loss per share (vs US$1.36 loss in FY 2019)

SRAX, Inc. Provides Revenue Guidance for the Second Quarter Of Fiscal Year 2021

SRAX, Inc. Releases the Shelf Registration Feature on the Sequire Platform

Brock Pierce Joins SRAX Board of Directors

SRAX trades high on Sequire platform reporting 3M retail investors

New 90-day high: US$3.95

Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?

New 90-day high: US$3.12

Analysts update estimates

SRAX, Inc., Annual General Meeting, Dec 31, 2020

Third quarter 2020 earnings released: US$0.45 loss per share

SRAX EPS misses by $0.14, beats on revenue

An undisclosed buyer acquired the remaining stake in the MD Asset of SRAX, Inc. (NasdaqCM:SRAX) for $8 million.

New 90-day low: US$2.34

SRAX, Inc. Announces Resignation of Kristoffer Nelson as Chief Operating Officer and as a Member of the Board, Effective October 16, 2020

SRAX, Inc. announced that it has received $14 million in funding from Serra Ventures, LLC

SRAX, Inc. (NasdaqCM:SRAX) completed the acquisition of LD Micro, Inc.

Analysts increase revenue estimates to US$5.72m

Analysts update estimates

New 90-day high - US$2.80

SRAX, Inc. announced that it has received $13 million in funding

SRAX, Inc.(NasdaqCM:SRAX) dropped from Russell Microcap Growth Index

SRAX, Inc. announced that it has received $11.8 million in funding

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin